BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,036 | +0.7% | 56,361 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $396,148 | -15.6% | 56,271 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $469,300 | -27.4% | 56,271 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $645,991 | -16.2% | 56,271 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $771,000 | +19.2% | 61,181 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $647,000 | -35.0% | 61,181 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $995,000 | -3.2% | 61,181 | -17.6% | 0.00% | 0.0% |
| Q4 2021 | $1,028,000 | -3.7% | 74,221 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,067,000 | -9.0% | 74,222 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,173,000 | +70.2% | 74,222 | +9.6% | 0.00% | +100.0% |
| Q1 2021 | $689,000 | +36.4% | 67,748 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $505,000 | +123.5% | 67,748 | +3.1% | 0.00% | 0.0% |
| Q3 2020 | $226,000 | -27.8% | 65,718 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $313,000 | +189.8% | 65,718 | +21.6% | 0.00% | – |
| Q1 2020 | $108,000 | -42.6% | 54,064 | -0.7% | 0.00% | – |
| Q4 2019 | $188,000 | +20.5% | 54,434 | 0.0% | 0.00% | – |
| Q3 2019 | $156,000 | -24.3% | 54,434 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $206,000 | -53.5% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $443,000 | +0.9% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $439,000 | +5.8% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $415,000 | +33.0% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $312,000 | +20.0% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $260,000 | -2.6% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $267,000 | -6.3% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $285,000 | -5.9% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $303,000 | -33.7% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $457,000 | +32.5% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $345,000 | +43.8% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $240,000 | +54.8% | 54,434 | 0.0% | 0.00% | – |
| Q2 2016 | $155,000 | +0.6% | 54,434 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $154,000 | -72.6% | 54,434 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $562,000 | -9.5% | 54,434 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $621,000 | -23.6% | 54,434 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $813,000 | +68.3% | 54,434 | +1.8% | 0.00% | +50.0% |
| Q1 2015 | $483,000 | -25.2% | 53,481 | +0.7% | 0.00% | 0.0% |
| Q4 2014 | $646,000 | +24.2% | 53,126 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $520,000 | -23.2% | 53,126 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $677,000 | +991.9% | 53,126 | +32.4% | 0.00% | – |
| Q2 2013 | $62,000 | – | 40,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |